Guidelines

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

Department of Hematology, University Medical Center Utrecht, The Netherlands
Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Turin, Italy
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Turin, Italy
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
Department of Haemato-oncology, University Hospital Ostrava and Faculty of Medicine, Czech Republic
Department of Hematology and Oncology, University of Freiburg Medical Center, Germany
Department of Medicine I, Wilhelminenspital Wien, Austria
Institute of Cancer Research, Royal Marsden Hospital, London, UK
Scientific Direction, Centro di Riferimento Oncologico della Basilicata, Istituto di Ricovero e Cura a Carattere Scientifico, Rionero in Vulture, Italy
Department of hematology at Vejle Hospital, Denmark
Department of Hematology, Memorial Hospital, Istanbul, Turkey
Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Greece
Department of Hematology, St. Olavs Hospital, Norwegian University of Science and Technology, Trondheim, Norway
Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands
Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
Department of Hematology, University Medical Center Utrecht, The Netherlands
Vol. 99 No. 6 (2014): June, 2014 https://doi.org/10.3324/haematol.2013.100552